Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients – Stanford Medical Center Report
Email Tweet Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19. Jun 30 2020 Aruna Subramanian is investigating an antiviral drug, favipiravir, to see if it reduces symptoms and viral shedding… Read More »